Treatment of Dentin Hypersensitivity Using Different Desensitizing Agents

NCT04340869 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-04-10

No results posted yet for this study

Summary

Treatment of Dentin Hypersensitivity Using Theobromine , Remin Pro , and Combination of Both Materials

Conditions

  • Dentin Sensitivity

Interventions

OTHER

Theobromine

Natural extract from Cocoa

OTHER

Remin Pro

Remin Pro

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-08-01
Completion
2022-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04340869 on ClinicalTrials.gov